Clinical Trial Results:
An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of three fixed doses of SSR411298 (10, 50, or 200mg daily) in elderly patients with Major Depressive Disorder
Summary
|
|
EudraCT number |
2008-001718-26 |
Trial protocol |
SK |
Global completion date |
16 Feb 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Apr 2016
|
First version publication date |
29 Apr 2016
|
Other versions |
|
Summary report(s) |
DFI10560 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.